Molecular monitoring of patients with ETV6‐PDGFRB rearrangement: Implications for therapeutic adaptation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2018-07, Vol.182 (1), p.148-152
Hauptverfasser:	Bidet, Audrey, Chollet, Claudine, Gardembas, Martine, Nicolini, Franck E., Genet, Philippe, Delmer, Alain, Caillot, Denis, Dulucq, Stéphanie, Mahon, Francois‐Xavier, Lippert, Eric
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Agents - therapeutic use chronic myeloid leukaemia ETV6‐PDGFRB Gene Rearrangement Hematologic Neoplasms - drug therapy Hematologic Neoplasms - genetics Hematology Human health and pathology Humans imatinib Imatinib Mesylate - therapeutic use Leukemia, Myeloid - drug therapy Leukemia, Myeloid - genetics Life Sciences Male Middle Aged Molecular chains Oncogene Proteins, Fusion - genetics quantitative reverse transcription‐PCR Real-Time Polymerase Chain Reaction - methods treatment free remission
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!